News
Private label iron supplement clinically shown to raise ferritin levels by 69%
PharmaLinea, a European provider of clinically supported private label food supplements, has announced the publication of a clinical trial on their liquid iron product for children. >Your< Iron Syrup was shown to increase ferritin levels by 69%, from values...
News
C4Diagnostics Announces CE Marking of C4Covid-19 HumanTM: a Covid-19 Saliva-Based Rapid Diagnostic Test
C4Diagnostics, a French biotech developing innovative In vitro diagnostic tests for infectious diseases, announced today the CE marking and commercialization of C4Covid-19 HumanTM for the rapid diagnostic of Covid-19 from a saliva sample. The performance of the test was...
News
CPhI Discover: pharma grows through partnering
The last year has been a hugely exiting time for pharma with the industry taking centre stage globally. It’s been a remarkable year of achievements, with the continued production of essential medicines, record levels of innovation and, of course,...
News
MedMinder Appoints David J. Shulkin, M.D. Chairman of the Board of Directors
MedMinder Systems Inc., the leading fully integrated, end-to-end pharmacy, medication adherence and connected care solution for elderly and polypharmacy patients, announced the appointment of David J. Shulkin, M.D. as Chairman of the Board of Directors (the “Board”).
A well-respected American...
Clinical Trials
Kintor Pharmaceuticals Announces Successful Proxalutamide COVID-19 Phase III Clinical Trial Initiation and Patient Dosing in U.S.
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the phase III clinical trial of proxalutamide for the treatment of male patients with mild or moderate COVID-19 symptoms in the United States...
News
Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India
Gilead Sciences, Inc. announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its voluntary licensing partners with technical assistance, support for the addition of new local manufacturing facilities and the donation...
News
U.S. Resumes Use of Johnson & Johnson COVID Vaccine
The FDA and Centers for Disease Control lifted their recommended pause of the Johnson & Johnson coronavirus vaccine, with no restrictions on who can receive it, following an extensive safety review. The move immediately opens up access to the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















